Want to see HELE full AI Analyst Report?
Top Page
Helen Of Troy
(NASDAQ:HELE)
Select Model
Select Model
Rating:57Neutral
Price Target:
$30.00
▲(2.95% Upside)
Action:Reiterated
Date:08/27/26
The score is primarily held back by weak financial performance—especially the steep recent profitability deterioration and higher leverage—partly cushioned by still-positive operating/free cash flow. Technicals are moderately supportive with the stock above key moving averages and neutral momentum. Earnings-call commentary improves the outlook via reaffirmed full-year adjusted targets and deleveraging, but ongoing tariff/margin pressures and second-half revenue risk temper confidence, while valuation remains constrained by a negative P/E and no dividend support.
Positive Factors
Brand Portfolio and Product Innovation
A diversified portfolio of recognized brands across home, outdoor, beauty and wellness supports customer relevance and cross-category resilience. Continued product launches, collaborations and distribution expansion can sustain shelf presence and create longer-term growth opportunities.
Negative Factors
Severe Profitability Deterioration
The swing to substantial net and operating losses materially weakens earnings quality and limits financial flexibility. Even with a solid gross margin, persistent cost pressure or charges could reduce reinvestment capacity and delay a durable recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Brand Portfolio and Product Innovation
A diversified portfolio of recognized brands across home, outdoor, beauty and wellness supports customer relevance and cross-category resilience. Continued product launches, collaborations and distribution expansion can sustain shelf presence and create longer-term growth opportunities.
Read all positive factors
Helen Of Troy Key Performance Indicators (KPIs)
Any
Revenue By Segment
Analyzes revenue from different business segments, revealing which product lines or services are contributing most to growth and which might need strategic attention.
Analyzes revenue from different business segments, revealing which product lines or services are contributing most to growth and which might need strategic attention.
Data provided by:
The Fly
The FlyHelen Of Troy (HELE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$673.14M
Dividend YieldN/A
Average Volume (3M)587.94K
Price to Earnings (P/E)―
Beta (1Y)1.12
Revenue Growth-2.08%
EPS Growth-23.88%
CountryUS
Employees1,854
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-17.99
Shares Outstanding23,292,060
10 Day Avg. Volume504,825
30 Day Avg. Volume587,941
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.51
Price to Sales (P/S)0.23
P/FCF Ratio3.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$26.50Price Target Upside-9.06% Downside
Rating ConsensusHold
Number of Analyst Covering3
EPS Forecast (FY)3.57
Revenue Forecast (FY)$1.81B
Helen Of Troy Business Overview & Revenue Model
Company Description
Helen of Troy Limited is a global consumer products enterprise that markets a diverse array of goods across the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. The company's operations are struct...
How the Company Makes Money
Helen of Troy primarily makes money by selling branded consumer products to retailers and other customers through wholesale and direct-to-consumer/e-commerce channels. Its core revenue stream is net product sales generated across its brand portfol...
Helen Of Troy Earnings Call Summary
Earnings Call Date:Jul 08, 2026
(Q1-2027)
| % Change Since: |
Next Earnings Date:Oct 07, 2026
Earnings Call Sentiment Positive
The call presented a generally constructive operational and financial start to fiscal 2027: Q1 sales growth (+8.2%) and segment gains (Home & Outdoor +9.5%, Beauty & Wellness +7%) beat expectations, debt was materially reduced and inventory improved, and management is investing in a new operating model and brand initiatives. However, notable headwinds persist — gross margin compression (~110 bps), ongoing tariff and inflationary pressure, supply-chain and geopolitical risk, one-time items affecting SG&A, and near-term cadence risk (possible second-half revenue decline). On balance, the positive delivery of better-than-expected top-line performance, deleveraging and clear strategic actions outweigh the near-term margin and macro risks.Positive Updates
Consolidated Sales Growth Outperformed Expectations
Net sales increased 8.2% year over year in Q1, coming in above company expectations; Q1 results benefited from ~$4–$5M favorable order phasing from earlier Prime Day timing.
Negative Updates
Gross Margin Compression
Consolidated gross profit margin decreased by 110 basis points to 46.0% year over year, driven by net unfavorable tariff impact, higher inventory obsolescence, and unfavorable customer mix within Home & Outdoor.
Read all updates
Q1-2027 Updates
Positive
Negative
Consolidated Sales Growth Outperformed Expectations
Net sales increased 8.2% year over year in Q1, coming in above company expectations; Q1 results benefited from ~$4–$5M favorable order phasing from earlier Prime Day timing.
Read all positive updates
Company Guidance
Management reiterated full‑year net sales guidance of $1.759–$1.831 billion (Home & Outdoor $859–$884M; Beauty & Wellness $900–$947M), maintained adjusted EBITDA of $190–$197M (implying +2.1% to +6.3% YoY) and adjusted EPS of $3.25–$3.75, and kept full‑year free cash flow at $85–$100M while raising planned capital expenditures by $2M; Q1 results beat expectations with consolidated sales +8.2% (helped by ~$4–$5M Prime Day order phasing), Home & Outdoor +9.5%, Beauty & Wellness +7.0%, International +1.1%, but Q1 free cash flow was slightly negative. Key margin and balance‑sheet metrics: consolidated gross margin down 110 bps to 46%, SG&A ratio 31% (vs. 45.1% LY, aided by a $55M pretax gain on a facility sale), adjusted operating margin 4% (down 30 bps), inventory $467M (down $17M YoY despite ~ $15M incremental tariffs in inventory), total debt reduced by $716M and net leverage to 3.48x (from 3.87x). Guidance embeds a Phase 1 tariff refund benefit now estimated at ~$9.2M (Q1 included a $1.8M pretax benefit), notes $71M of EPA tariffs paid not in Phase 1, expects H1 sales growth low‑ to mid‑single digits and a second‑half low‑single‑digit decline, anticipates roughly 20% of annual EPS in H1 (about 15% in Q2), and warns refund timing and ongoing cost inflation (commodities, freight, CNY, supply disruption) could affect results.Helen Of Troy Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
46
Neutral
Cash Flow
54
Neutral
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.82B | 1.79B | 1.91B | 2.01B | 2.07B | 2.22B |
| Gross Profit | 825.54M | 815.69M | 914.41M | 948.66M | 899.35M | 953.19M |
| EBITDA | -261.21M | -727.80M | 268.61M | 301.32M | 286.94M | 310.88M |
| Net Income | -412.50M | -898.98M | 123.75M | 168.59M | 143.27M | 223.76M |
Balance Sheet | ||||||
| Total Assets | 2.08B | 2.12B | 3.13B | 2.84B | 2.91B | 2.82B |
| Cash, Cash Equivalents and Short-Term Investments | 24.18M | 18.89M | 18.87M | 18.50M | 29.07M | 33.38M |
| Total Debt | 771.35M | 833.70M | 956.84M | 702.93M | 977.08M | 856.96M |
| Total Liabilities | 1.24B | 1.32B | 1.45B | 1.20B | 1.42B | 1.50B |
| Stockholders Equity | 843.52M | 798.20M | 1.68B | 1.64B | 1.49B | 1.33B |
Cash Flow | ||||||
| Free Cash Flow | 80.49M | 131.91M | 83.14M | 269.42M | 33.38M | 62.78M |
| Operating Cash Flow | 112.16M | 171.14M | 113.21M | 306.07M | 208.24M | 140.82M |
| Investing Cash Flow | 47.54M | -34.43M | -263.09M | 5.45M | -319.33M | -438.91M |
| Financing Cash Flow | -160.69M | -136.69M | 150.25M | -322.09M | 106.78M | 286.35M |
Helen Of Troy Technical Analysis
Positive
29.14
Price Trends
28.19
Positive
25.71
Positive
22.00
Positive
Market Momentum
0.20
Positive
52.87
Neutral
50.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HELE, the sentiment is Positive. The current price of 29.14 is above the 20-day moving average (MA) of 28.90, above the 50-day MA of 28.19, and above the 200-day MA of 22.00, indicating a bullish trend. The MACD of 0.20 indicates Positive momentum. The RSI at 52.87 is Neutral, neither overbought nor oversold. The STOCH value of 50.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HELE.
Helen Of Troy Risk Analysis
Helen Of Troy disclosed 28 risk factors in its most recent earnings report. Helen Of Troy reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Helen Of Troy Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $33.40M | 13.31 | 22.24% | 6.56% | 3.23% | -3.58% | |
69 Neutral | $2.05B | 26.69 | 4.22% | 2.12% | 0.82% | 23.29% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
58 Neutral | $1.33B | -14.33 | -6.27% | 2.17% | -7.00% | -246.78% | |
57 Neutral | $673.14M | -1.62 | -48.24% | ― | -2.08% | -23.88% | |
51 Neutral | $236.08M | -1.09 | -29.42% | 4.72% | -15.44% | -319.79% | |
47 Neutral | $84.60M | -3.04 | -47.84% | ― | -6.45% | -44.06% |
* Consumer Defensive Sector Average
HELE
Helen Of Troy
29.14
4.83
19.87%
NUS
Nu Skin
4.84
-6.77
-58.32%
SPB
Spectrum Brands Holdings
88.89
34.36
63.02%
UG
United-Guardian
7.19
-0.27
-3.68%
EPC
Edgewell Personal Care
28.65
5.70
24.85%
SKIN
Beauty Health
0.69
-1.36
-66.42%
Helen Of Troy Corporate Events
Business Operations and StrategyShareholder Meetings
Helen Of Troy Expands Stock Incentive Plan Authorization
Positive
Aug 26, 2026
At the August 25, 2026 annual general meeting, Helen of Troy shareholders approved an amendment to the 2025 Stock Incentive Plan, adding authorization for 965,000 additional common shares for equity awards. The expansion of the plan increases the ...
Business Operations and StrategyRegulatory Filings and Compliance
Helen of Troy Releases Fiscal 2026 Sustainability Report
Neutral
Jun 4, 2026
On June 4, 2026, Helen of Troy Limited released its fiscal year 2026 Sustainability Report, making the document available on its corporate website for investors and other stakeholders. The filing, signed the same day by Chief Financial Officer Bri...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.